Harmony Biosciences Holdings, Inc. (HRMY) Market Cap & Valuation Ratios
Harmony Biosciences Holdings, Inc. (HRMY) has a market cap of $2.1B, a trailing P/E of 11.7 and a price-to-sales ratio of 2.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HRMYHarmony Biosciences Holdings, Inc.Follow HRMY — free
—
Price chart with a free account
- Market cap
- 2.1B
- P/E TTM
- 11.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
biotechnology · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| HRMY | 2.1 | 11.7 | 1.7 | 6.2 | 16.9% | +24% | 24% | 35% |
| FTRE | 2.2 | — | 1.2 | 46.4 | 8.7% | -2% | -0.4% | -0.7% |
| AUPH | 2.2 | — | 5.8 | 10.6 | 7.8% | +20% | 48% | 33% |
| PGEN | 2.2 | — | 26.5 | — | -5.2% | +147% | -46% | -33% |
| AGIO | 2.2 | — | 16.0 | — | — | +141% | -467% | -41% |
| VCEL | 2.2 | 90.5 | 6.6 | 64.7 | 2.8% | +23% | 6% | 7% |
| BHVN | 2.1 | — | — | — | — | — | — | -437% |
| IMNM | 2.0 | — | — | — | -10.7% | — | — | -125% |
| VERA | 2.0 | — | — | — | — | — | — | -90% |
| ZYME | 2.0 | — | 49.1 | — | -6.0% | -70% | -419% | — |
| RXRX | 2.0 | — | 26.4 | — | — | -15% | — | -136% |
| Median of these 10 | 90.5 | 16.0 | 46.4 | -1.2% | +20% | -23% | -41% |
P/E 11.7 vs. a peer median of 90.5; EV/Sales 1.7 vs. 16.0. HRMY's own P/E sits at the 26th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesHarmony Biosciences Holdings, Inc. — questions
- What is Harmony Biosciences Holdings, Inc.'s market cap?
- $2.1B.
- What is Harmony Biosciences Holdings, Inc.'s P/E ratio?
- 11.7 on trailing twelve-month earnings to 2026-06-30.
- What is Harmony Biosciences Holdings, Inc.'s price-to-sales ratio?
- 2.2.
Every figure on this page comes from Harmony Biosciences Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.